PL368409A1 - Pochodne triazolilo-imidazopirydyny i triazolilopuryn użyteczne jako ligandy receptora adenyzowego A2a oraz ich zastosowanie jako leków - Google Patents

Pochodne triazolilo-imidazopirydyny i triazolilopuryn użyteczne jako ligandy receptora adenyzowego A2a oraz ich zastosowanie jako leków

Info

Publication number: PL368409A1
Authority: PL; Poland
Prior art keywords: linear; branched; alkyl; aryl; alkenyl
Prior art date: 2001-07-31

Application number

PL02368409A

Other languages

English (en)

Other versions

PL217269B1 (pl

Inventor

Giorgio Tarzia

Giovanni Piersanti

Patrizia Minetti

Cesare Maria Assunta Di

Grazia Gallo

Fabrizio Giorgi

Luca Giorgi

Original Assignee

Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2001-07-31

Filing date

2002-07-25

Publication date

2005-03-21

2002-07-25 Application filed by Sigma-Tau Industrie Farmaceutiche Riunite S.P.A. filed Critical Sigma-Tau Industrie Farmaceutiche Riunite S.P.A.

2005-03-21 Publication of PL368409A1 publication Critical patent/PL368409A1/pl

2014-06-30 Publication of PL217269B1 publication Critical patent/PL217269B1/pl

Links

239000003814 drug Substances 0.000 title abstract 2
OIRDTQYFTABQOQ-KQYNXXCUSA-N adenosine Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O OIRDTQYFTABQOQ-KQYNXXCUSA-N 0.000 title 2
239000002126 C01EB10 - Adenosine Substances 0.000 title 1
229960005305 adenosine Drugs 0.000 title 1
239000003446 ligand Substances 0.000 title 1
125000000217 alkyl group Chemical group 0.000 abstract 5
125000005915 C6-C14 aryl group Chemical group 0.000 abstract 4
125000004169 (C1-C6) alkyl group Chemical group 0.000 abstract 3
125000003342 alkenyl group Chemical group 0.000 abstract 3
125000002924 primary amino group Chemical group [H]N([H])* 0.000 abstract 3
125000004191 (C1-C6) alkoxy group Chemical group 0.000 abstract 2
125000003302 alkenyloxy group Chemical group 0.000 abstract 2
125000003118 aryl group Chemical group 0.000 abstract 2
150000001875 compounds Chemical class 0.000 abstract 2
229910052736 halogen Inorganic materials 0.000 abstract 2
150000002367 halogens Chemical class 0.000 abstract 2
125000002887 hydroxy group Chemical group [H]O* 0.000 abstract 2
125000001424 substituent group Chemical group 0.000 abstract 2
125000006727 (C1-C6) alkenyl group Chemical group 0.000 abstract 1
102000007471 Adenosine A2A receptor Human genes 0.000 abstract 1
108010085277 Adenosine A2A receptor Proteins 0.000 abstract 1
125000006577 C1-C6 hydroxyalkyl group Chemical group 0.000 abstract 1
101100294115 Caenorhabditis elegans nhr-4 gene Chemical group 0.000 abstract 1
208000018737 Parkinson disease Diseases 0.000 abstract 1
125000004183 alkoxy alkyl group Chemical group 0.000 abstract 1
125000003277 amino group Chemical group 0.000 abstract 1
125000006620 amino-(C1-C6) alkyl group Chemical group 0.000 abstract 1
239000005557 antagonist Substances 0.000 abstract 1
229910052739 hydrogen Inorganic materials 0.000 abstract 1
239000001257 hydrogen Substances 0.000 abstract 1
125000004435 hydrogen atom Chemical group [H]* 0.000 abstract 1
150000003839 salts Chemical class 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/519—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with heterocyclic rings
- A61K31/52—Purines, e.g. adenine
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
- A61P25/16—Anti-Parkinson drugs
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D473/00—Heterocyclic compounds containing purine ring systems
- C07D473/26—Heterocyclic compounds containing purine ring systems with an oxygen, sulphur, or nitrogen atom directly attached in position 2 or 6, but not in both
- C07D473/32—Nitrogen atom
- C07D473/34—Nitrogen atom attached in position 6, e.g. adenine

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Animal Behavior & Ethology (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Epidemiology (AREA)
Neurosurgery (AREA)
Neurology (AREA)
Biomedical Technology (AREA)
Psychology (AREA)
Urology & Nephrology (AREA)
Heart & Thoracic Surgery (AREA)
Hospice & Palliative Care (AREA)
Cardiology (AREA)
Vascular Medicine (AREA)
Psychiatry (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

PL368409A 2001-07-31 2002-07-25 Pochodne triazoliloimidazopirydyny i triazolilopuryny, zawierająca je kompozycja farmaceutyczna, ich zastosowanie, sposób ich otrzymywania oraz związki pośrednie wykorzystywane w tym sposobie PL217269B1 (pl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT2001RM000465A ITRM20010465A1 (it)	2001-07-31	2001-07-31	Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam

Publications (2)

Publication Number	Publication Date
PL368409A1 true PL368409A1 (pl)	2005-03-21
PL217269B1 PL217269B1 (pl)	2014-06-30

Family

ID=11455703

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
PL368409A PL217269B1 (pl)	2001-07-31	2002-07-25	Pochodne triazoliloimidazopirydyny i triazolilopuryny, zawierająca je kompozycja farmaceutyczna, ich zastosowanie, sposób ich otrzymywania oraz związki pośrednie wykorzystywane w tym sposobie

Country Status (18)

Country	Link
US (2)	US7230102B2 (pl)
EP (1)	EP1412354B1 (pl)
JP (1)	JP4366186B2 (pl)
KR (1)	KR100884818B1 (pl)
CN (1)	CN1271070C (pl)
AT (1)	ATE325796T1 (pl)
AU (1)	AU2002326146B2 (pl)
BR (1)	BR0211550A (pl)
CA (1)	CA2451279C (pl)
DE (1)	DE60211343T2 (pl)
DK (1)	DK1412354T3 (pl)
ES (1)	ES2263810T3 (pl)
HU (1)	HU228985B1 (pl)
IT (1)	ITRM20010465A1 (pl)
MX (1)	MXPA04000886A (pl)
PL (1)	PL217269B1 (pl)
PT (1)	PT1412354E (pl)
WO (1)	WO2003011864A1 (pl)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
ES2247356T3 (es) *	2001-06-29	2006-03-01	Cv Therapeutics, Inc.	Derivados de purina com antagonistas del receptor a2b de adenosina.
ITRM20010465A1 (it) *	2001-07-31	2003-01-31	Sigma Tau Ind Farmaceuti	Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam
ES2279903T3 (es) *	2001-12-18	2007-09-01	Cv Therapeutics, Inc.	Antagonistas del receptor a2a de adenosina.
CN1938307B (zh)	2004-03-26	2010-06-16	大日本住友制药株式会社	9-取代的8-氧代腺嘌呤
EP2007765B1 (en) *	2006-03-23	2012-06-27	Novartis AG	Immunopotentiating compounds
JP2009542645A (ja)	2006-07-05	2009-12-03	アストラゼネカ・アクチエボラーグ	Ｔｌｒ７のモジュレーターとして作用する８−オキソアデニン誘導体
TW200831105A (en)	2006-12-14	2008-08-01	Astrazeneca Ab	Novel compounds
ES2457316T3 (es)	2007-03-19	2014-04-25	Astrazeneca Ab	Compuestos 8-oxo-adenina 9 sustituidos como moduladores del receptor similares a toll (TLR7)
ATE530549T1 (de)	2007-03-19	2011-11-15	Astrazeneca Ab	9-substituierte 8-oxoadeninverbindungen als modulatoren des toll-like-receptor (tlr7)
EP2138497A4 (en)	2007-03-20	2012-01-04	Dainippon Sumitomo Pharma Co	NEW ADENINE CONNECTION
AR065784A1 (es) *	2007-03-20	2009-07-01	Dainippon Sumitomo Pharma Co	Derivados de 8-oxo adenina,medicamentos que los contienen y usos como agentes terapeuticos para enfermedades alergicas, antivirales o antibacterianas.
DK2069324T3 (da)	2007-03-20	2013-09-02	Curis Inc	Fusioneret aminopyridin som hsp90-inhibitorer
DK2155743T3 (da) *	2007-05-08	2012-11-05	Astrazeneca Ab	Imidazoquinoliner med immunmodulerende egenskaber
UY31531A1 (es)	2007-12-17	2009-08-03		Sales derivadas de 8-oxoadenina composiciones farmacéuticas que las contienen y su uso en terapia como moduladores de receptor tipo toll (tlr)
US8865896B2 (en)	2008-01-17	2014-10-21	Astrazeneca Aktiebolag	Method for preparing adenine compound
JPWO2009091031A1 (ja) *	2008-01-17	2011-05-26	大日本住友製薬株式会社	アデニン化合物の製造方法
TWI473614B (zh) *	2008-05-29	2015-02-21	Kyowa Hakko Kirin Co Ltd	Anti-analgesic inhibitors
KR20110036602A (ko)	2008-07-03	2011-04-07	서트리스 파마슈티컬즈, 인코포레이티드	시르투인 조절제로서의 벤즈이미다졸 및 관련 유사체
WO2010010908A1 (ja) *	2008-07-23	2010-01-28	協和発酵キリン株式会社	片頭痛治療剤
DK2408775T3 (en) *	2009-03-20	2015-07-27	Sigma Tau Ind Farmaceuti	Oxidized derivatives of triazolylpuriner useful as ligands of the adenosine A 2A receptor, and their use as medicaments
TWI398255B (zh)	2009-11-13	2013-06-11	Academia Sinica	結合至腺苷酸ａａ受體和腺苷酸轉運子以預防及治療神經退化疾病的雙功能化合物
WO2011068233A1 (en) *	2009-12-03	2011-06-09	Dainippon Sumitomo Pharma Co., Ltd.	Imidazoquinolines which act via toll - like receptors (tlr)
WO2012070601A1 (ja) *	2010-11-24	2012-05-31	ヤマサ醤油株式会社	新規な２－アルキニル－ｎ９－プロパギルアデニンおよびその医薬用途
JP5978225B2 (ja)	2010-12-16	2016-08-24	大日本住友製薬株式会社	治療に有用なイミダゾ［４，５−ｃ］キノリン−１−イル誘導体
JP5978226B2 (ja)	2010-12-17	2016-08-24	大日本住友製薬株式会社	プリン誘導体
CN105189495A (zh) *	2013-03-15	2015-12-23	先正达参股股份有限公司	新颖的杀微生物剂
CN105622495A (zh) *	2016-03-23	2016-06-01	叶芳	4-氯-3-硝基吡啶及其制备方法
ES2957548T3 (es) *	2016-04-15	2024-01-22	Univ Oxford Innovation Ltd	Moduladores del receptor de adenosina para el tratamiento de los trastornos del ritmo circadiano
WO2025080645A1 (en) *	2023-10-10	2025-04-17	Regranion, Llc	Methods and compositions for treating bullous pemphigoid
GB202319534D0 (en) *	2023-12-19	2024-01-31	Circadian Therapeutics Ltd	Dosage regimen

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
AU626983B2 (en)	1989-01-31	1992-08-13	Whitby Research, Inc.	N6-substituted 9-methyladenines
US5670501A (en)	1994-09-01	1997-09-23	Discovery Therapeutics, Inc.	N-substituted 9-alkyladenines
EP1300147A1 (en)	1998-01-05	2003-04-09	Eisai Co. Ltd	Purine compounds and adenosine A2 receptor antagonist as preventive or therapeutic agent for diabetes mellitus
GB9915437D0 (en)	1999-07-01	1999-09-01	Cerebrus Ltd	Chemical compounds III
ES2247356T3 (es) *	2001-06-29	2006-03-01	Cv Therapeutics, Inc.	Derivados de purina com antagonistas del receptor a2b de adenosina.
ITRM20010465A1 (it)	2001-07-31	2003-01-31	Sigma Tau Ind Farmaceuti	Derivati della triazolil-imidazopiridina e delle triazolilpurine utili come ligandi del recettore a2a dell'adenosina e loro uso come medicam

2001
- 2001-07-31 IT IT2001RM000465A patent/ITRM20010465A1/it unknown
2002
- 2002-07-25 JP JP2003517056A patent/JP4366186B2/ja not_active Expired - Fee Related
- 2002-07-25 CN CNB028138481A patent/CN1271070C/zh not_active Expired - Fee Related
- 2002-07-25 PT PT02760555T patent/PT1412354E/pt unknown
- 2002-07-25 DK DK02760555T patent/DK1412354T3/da active
- 2002-07-25 PL PL368409A patent/PL217269B1/pl unknown
- 2002-07-25 AU AU2002326146A patent/AU2002326146B2/en not_active Ceased
- 2002-07-25 EP EP02760555A patent/EP1412354B1/en not_active Expired - Lifetime
- 2002-07-25 KR KR1020047000173A patent/KR100884818B1/ko not_active Expired - Fee Related
- 2002-07-25 MX MXPA04000886A patent/MXPA04000886A/es active IP Right Grant
- 2002-07-25 WO PCT/IT2002/000489 patent/WO2003011864A1/en not_active Ceased
- 2002-07-25 HU HU0401987A patent/HU228985B1/hu not_active IP Right Cessation
- 2002-07-25 DE DE60211343T patent/DE60211343T2/de not_active Expired - Lifetime
- 2002-07-25 ES ES02760555T patent/ES2263810T3/es not_active Expired - Lifetime
- 2002-07-25 AT AT02760555T patent/ATE325796T1/de active
- 2002-07-25 BR BR0211550-6A patent/BR0211550A/pt not_active IP Right Cessation
- 2002-07-25 CA CA2451279A patent/CA2451279C/en not_active Expired - Fee Related
- 2002-07-25 US US10/484,491 patent/US7230102B2/en not_active Expired - Fee Related
2007
- 2007-05-04 US US11/797,566 patent/US7528252B2/en not_active Expired - Fee Related

Also Published As

Publication number	Publication date
DK1412354T3 (da)	2006-09-18
US20070249638A1 (en)	2007-10-25
MXPA04000886A (es)	2004-06-03
JP2005500355A (ja)	2005-01-06
ITRM20010465A0 (it)	2001-07-31
PT1412354E (pt)	2006-09-29
KR100884818B1 (ko)	2009-02-20
CA2451279A1 (en)	2003-02-13
BR0211550A (pt)	2004-07-13
JP4366186B2 (ja)	2009-11-18
ITRM20010465A1 (it)	2003-01-31
HK1068334A1 (en)	2005-04-29
WO2003011864A1 (en)	2003-02-13
HU228985B1 (en)	2013-07-29
CA2451279C (en)	2011-05-10
HUP0401987A2 (hu)	2005-01-28
DE60211343D1 (de)	2006-06-14
DE60211343T2 (de)	2007-05-10
US7528252B2 (en)	2009-05-05
ATE325796T1 (de)	2006-06-15
HUP0401987A3 (en)	2012-12-28
KR20040023641A (ko)	2004-03-18
PL217269B1 (pl)	2014-06-30
CN1525974A (zh)	2004-09-01
US7230102B2 (en)	2007-06-12
EP1412354B1 (en)	2006-05-10
ES2263810T3 (es)	2006-12-16
AU2002326146B2 (en)	2008-05-01
EP1412354A1 (en)	2004-04-28
US20040204428A1 (en)	2004-10-14
CN1271070C (zh)	2006-08-23

Publication	Publication Date	Title
PL368409A1 (pl)	2005-03-21	Pochodne triazolilo-imidazopirydyny i triazolilopuryn użyteczne jako ligandy receptora adenyzowego A2a oraz ich zastosowanie jako leków
MY126862A (en)	2006-10-31	Purine derivatives inhibitors of tyrosine protein kinase syk
TW200716528A (en)	2007-05-01	Cyclopropanecarboxamide derivatives
HUP0401047A2 (hu)	2004-09-28	Triazolo[4,5-d]pirimidin-származékok, alkalmazásuk purinergikus receptor-antagonistákként és a vegyületet tartalmazó gyógyszerkészítmények
MY139357A (en)	2009-09-30	Novel benzoimidazole derivatives useful as antiproliferative agents
NL350075I2 (pl)	2017-02-07
GEP20084357B (en)	2008-04-29	Pyrimidine derivatives for the treatment of abnormal cell growth
YU55603A (sh)	2006-05-25	Derivati purina kao antagonisti purinergiskog receptora
ATE289602T1 (de)	2005-03-15	Quinolin-2-on-derivate verwendbar als antikrebsmittel
MXPA04000577A (es)	2004-04-20	Derivados de dolastatina 10.
MXPA04001240A (es)	2004-06-03	Analogos antitumorales.
MY137156A (en)	2008-12-31	Dual nk1/nk3 derivatives
TW200517109A (en)	2005-06-01	Substituted pyridinones
MXPA05010621A (es)	2005-11-23	Pirimidinonas sustituidas.
MY139612A (en)	2009-10-30	Benzoxazine derivatives as 5-th6 modulators and uses thereof
ATE233754T1 (de)	2003-03-15	Diphenyl-piperidin derivate
MY136824A (en)	2008-11-28	Substituted benzoxazinones and uses thereof
MXPA04000407A (es)	2004-03-18	Derivados de fenilacetamido-tiazol, procedimiento para su preparacion y uso como agentes antitumorales.
MY138466A (en)	2009-06-30	Aminoalkoxyndoles as 5-ht6-receptor ligands for the treatment of cns-disorders
BG104717A (en)	2001-07-31	Water soluble azoles as broad-spectrum antifungals
PT1022276E (pt)	2003-10-31	Derivados de epoxissuccinamida
YU64400A (sh)	2003-01-31	Aril fuzirana azapoliciklična jedinjenja
NZ515407A (en)	2004-03-26	4-Phenyl-pyrimidine derivatives
DE69916066D1 (de)	2004-05-06	Neue benzoxazole mit pde-hemmender wirkung
IL179171A0 (en)	2007-03-08	Alkyl substituted indoloquinoxalines